2015 Regular Session
|At the request of:||(at the request of House Interim Committee on Health Care)|
|Bill Title:||Relating to treatments for patients with terminal diseases.|
Creates method by which health care practitioner may offer to treat patient who has terminal disease with investigational product not approved by United States Food and Drug Administration.
Provides protections, including waiver of liability, for health care practitioners, health care facilities, professional organizations or associations and manufacturers or suppliers of investigational products that comply with Act. Sunsets Act on January 2, 2022.
|Chapter Number:||Chapter 819|
|Fiscal Impact:||Has Minimal Fiscal Impact|
|Revenue Impact:||No Revenue Impact|
|Measure Analysis:||Staff Measure Summary / Impact Statements|
|Current Location:||Chapter Number Assigned|
|Potential Conflicts of Interest/Vote Explanations:||Potential Conflicts of Interest/Vote Explanation Documents|